Rigel Pharmaceuticals, Inc. (RIGL)
45.16
-0.72
(-1.58%)
USD |
NASDAQ |
Aug 24, 16:00
45.16
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Debt to Equity Ratio : 0.0939 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0939 |
| March 31, 2026 | 0.1143 |
| December 31, 2025 | 0.1362 |
| September 30, 2025 | 0.5176 |
| June 30, 2025 | 0.745 |
| March 31, 2025 | 3.289 |
| December 31, 2024 | 18.24 |
| September 30, 2024 | -4.115 |
| June 30, 2024 | -2.017 |
| March 31, 2024 | -1.910 |
| December 31, 2023 | -2.115 |
| September 30, 2023 | -1.910 |
| June 30, 2023 | -2.158 |
| March 31, 2023 | -2.504 |
| December 31, 2022 | -3.052 |
| September 30, 2022 | -2.444 |
| June 30, 2022 | -11.24 |
| March 31, 2022 | 6.435 |
| December 31, 2021 | 1.006 |
| September 30, 2021 | 0.7706 |
| June 30, 2021 | 0.5937 |
| March 31, 2021 | 0.4733 |
| December 31, 2020 | 1.149 |
| September 30, 2020 | 0.8066 |
| June 30, 2020 | 0.6822 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.4448 |
| December 31, 2019 | 0.6748 |
| September 30, 2019 | 0.5547 |
| June 30, 2019 | 0.3843 |
| March 31, 2019 | 0.3167 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ironwood Pharmaceuticals, Inc. | -2.452 |
| Cytokinetics, Inc. | -7.324 |
| Perspective Therapeutics, Inc. | 0.0122 |
| Capricor Therapeutics, Inc. | 0.3698 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 521.07M |
| Total Liabilities (Quarterly) | 95.64M |
| Shareholders Equity (Quarterly) | 425.42M |
| Current Ratio | 1.941 |
| Net Debt Paydown Yield | 0.58% |